In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

La Jolla names new CFO

This article was originally published in Scrip

Executive Summary

San Diego-based La Jolla Pharmaceutical has named Dennis Mulroy chief financial officer. Prior to joining La Jolla, Mr Mulroy was CFO of Taxus Cardium Pharmaceuticals, a publicly traded biotechnology company, since 2005. Before joining Taxus Cardium, Mr Mulroy was CFO of Molecular Imaging and SeraCare Life Sciences and held financial management positions of increasing responsibility at several other companies.

Advertisement
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC028371

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel